PEG-3350 and Electrolytes

Product NDC

62175-446

11-digit product format

621750446

Labeler code

62175

Product ID

62175-446_996136ce-e62b-46a1-a869-8c1454aee47f

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM BICARBONATE, and SODIUM SULFATE

Dosage form

POWDER, FOR SOLUTION

Route

ORAL

Labeler

Lannett Company, Inc.

Application

NDA018983

Marketing category

NDA AUTHORIZED GENERIC

Marketing start

1984-10-26

Marketing end

0000-00-00

Substance

POLYETHYLENE GLYCOL 3350; SODIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM SULFATE

Active strength

240 g/4L; g/4L; g/4L; g/4L; g/4L

Pharmacologic classes

Osmotic Activity [MoA],Osmotic Laxative [EPC],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]

NDC exclude flag

No

Listing certified through

2021-12-31

Current FDA listing

Historical FDA.report record